JP2021533825A5 - - Google Patents

Info

Publication number
JP2021533825A5
JP2021533825A5 JP2021531197A JP2021531197A JP2021533825A5 JP 2021533825 A5 JP2021533825 A5 JP 2021533825A5 JP 2021531197 A JP2021531197 A JP 2021531197A JP 2021531197 A JP2021531197 A JP 2021531197A JP 2021533825 A5 JP2021533825 A5 JP 2021533825A5
Authority
JP
Japan
Prior art keywords
protein
pore
optionally
fragment
liposome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021531197A
Other languages
English (en)
Japanese (ja)
Other versions
JP7687683B2 (ja
JP2021533825A (ja
Filing date
Publication date
Priority claimed from GBGB1812992.4A external-priority patent/GB201812992D0/en
Application filed filed Critical
Publication of JP2021533825A publication Critical patent/JP2021533825A/ja
Publication of JP2021533825A5 publication Critical patent/JP2021533825A5/ja
Application granted granted Critical
Publication of JP7687683B2 publication Critical patent/JP7687683B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021531197A 2018-08-09 2019-08-09 リポソームの調製方法 Active JP7687683B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1812992.4 2018-08-09
GBGB1812992.4A GB201812992D0 (en) 2018-08-09 2018-08-09 Liposomes
PCT/GB2019/052239 WO2020030923A1 (en) 2018-08-09 2019-08-09 Method for preparing liposomes

Publications (3)

Publication Number Publication Date
JP2021533825A JP2021533825A (ja) 2021-12-09
JP2021533825A5 true JP2021533825A5 (https=) 2022-08-12
JP7687683B2 JP7687683B2 (ja) 2025-06-03

Family

ID=63667012

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021531197A Active JP7687683B2 (ja) 2018-08-09 2019-08-09 リポソームの調製方法

Country Status (9)

Country Link
US (2) US12233162B2 (https=)
EP (1) EP3833330A1 (https=)
JP (1) JP7687683B2 (https=)
CN (1) CN113286578A (https=)
AU (1) AU2019317788B2 (https=)
CA (1) CA3108864A1 (https=)
GB (1) GB201812992D0 (https=)
IL (1) IL280703A (https=)
WO (1) WO2020030923A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11931458B2 (en) 2021-01-11 2024-03-19 Babak Ghalili Exosome systems, products and methods
CN114259573B (zh) * 2022-01-06 2023-06-20 中国人民解放军军事科学院军事医学研究院 一种含有胆碱酯酶重活化剂的脑靶向脂质体及其制备方法和用途
WO2023195976A1 (en) * 2022-04-05 2023-10-12 Babak Ghalili Exosome systems, products and methods
CN115990270B (zh) * 2022-07-14 2023-08-11 郑州大学 一种抑制肿瘤干性的纳米载体及其制备方法和应用
WO2025067020A1 (zh) * 2023-09-26 2025-04-03 天津医科大学眼科医院 一种成体干细胞源的细胞内纳米囊泡在抗衰老和毛囊再生中的应用
CN118272405B (zh) * 2024-02-28 2025-01-07 浙江大学杭州国际科创中心 一种高效分泌纳米抗体药物的基因工程菌及其应用
WO2025259543A1 (en) * 2024-06-09 2025-12-18 Mercury Bio, Inc. Targeted delivery of cas13d and associated guide shrna to silence targeted rnas via yeast extracellular vesicles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012096926A2 (en) * 2011-01-10 2012-07-19 President And Fellows Of Harvard College Method for delivering agents into cells using bacterial toxins
WO2013138427A1 (en) 2012-03-16 2013-09-19 The General Hospital Corporation Microvesicle-mediated delivery of therapeutic molecules
GB201311057D0 (en) * 2013-06-21 2013-08-07 Univ Greenwich Antisense oligonucleotide compositions
WO2015002956A1 (en) 2013-07-01 2015-01-08 Ohio State Innovation Foundation Exosome delivery system
US20150275229A1 (en) 2014-03-25 2015-10-01 William Douglas Meadow, JR. Self-iterating exosomal vector for effective biomolecular transfers
WO2016187717A1 (en) * 2015-05-26 2016-12-01 Exerkine Corporation Exosomes useful for genome editing
GB2552473A (en) 2016-07-21 2018-01-31 Evox Therapeutics Ltd Surface decoration of extracellular vesicles

Similar Documents

Publication Publication Date Title
JP2021533825A5 (https=)
US8734853B2 (en) HDL particles for delivery of nucleic acids
JP6621409B2 (ja) C/EBPα小分子活性化RNA組成物
KR101963885B1 (ko) 세포투과성이 향상된 펩티드 핵산 복합체 및 이를 포함하는 약학적 조성물
CN105683377B (zh) 呼吸疾病相关基因特异性siRNA、含有siRNA的双螺旋寡RNA结构、含有它们的组合物用于预防或治疗呼吸疾病
US20090012021A1 (en) Delivery of Sirna by Neutral Lipid Compositions
US20070014840A1 (en) Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
KR20190096148A (ko) 엔도좀 탈출능을 갖는 펩티드 핵산 복합체 및 이의 용도
KR20220104118A (ko) 핵산 복합체를 함유하는 피부 투과성 전달체 및 이의 용도
CN104024413B (zh) 小干扰RNA及其应用和抑制plk1基因表达的方法
CN118043461A (zh) 方法
JP7032140B2 (ja) 嚢胞性線維症の処置のための方法及び医薬組成物
WO2023024230A1 (zh) 一种含有C/EBPα-saRNA的组合物
KR102603739B1 (ko) 암 특이적 핵산 분자 전달용 조성물 및 그 용도
WO2023048572A1 (en) Targeted lipid nanoparticle formulations
KR20160023784A (ko) 안티센스 올리고뉴클레오티드 조성물
JP7525578B2 (ja) C/EBPα小分子活性化RNA組成物
US20120070486A1 (en) Methods and compositions related to prefoldin and its regulation
JP5872898B2 (ja) 標的遺伝子の発現を抑制する組成物
JP2026511324A (ja) 手術関連線維症治療のための遺伝子編集
CN119932107A (zh) 纤维化髓核细胞靶向性抗FAP scFv工程化外泌体负载SKI mRNA递送系统的制备方法及其应用
WO2024175775A1 (en) Use of micrornas in the treatment of lung diseases
WO2025261963A1 (en) Therapeutic delivery compositions
WO2025162482A1 (zh) 用于预防和治疗癌症转移的aso及其用途
Thomas The Use of Supercharged Coiled-Coil Proteins in Combination with Lipid Carriers For Efficient SiRna Delivery